Maha Katabi's Net Worth
$0
Who is Maha Katabi?
Maha Katabi does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vera Therapeutics, Inc., , Aerovate Therapeutics, Inc., Inozyme Pharma, Inc., Bolt Biotherapeutics, Inc., Akouos, Inc., and RayzeBio, Inc..
SEC CIK
Maha Katabi's CIK is 0001720685
Past Insider Trading and Trends
2023 was Maha Katabi's most active year for acquiring shares with 4 total transactions. Maha Katabi's most active month to acquire stocks was the month of April. 2024 was Maha Katabi's most active year for disposing of shares, totalling 1 transactions. Maha Katabi's most active month to dispose stocks was the month of January. 2023 saw Maha Katabi paying a total of $47,496.16 for 53,362 shares, this is the most they've acquired in one year. In 2024 Maha Katabi cashed out on 18,235 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Inozyme Pharma, Inc. (INZY) Snapshot price: $4.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.03M |
$16.00 |
—
| 2.03M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bolt Biotherapeutics, Inc. (BOLT) Snapshot price: $0.641
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.75M |
$20.00 |
—
| 2.75M |
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akouos, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.52M |
$17.00 |
—
| 1.52M |
Jun 30
| |||
| No matching records found | |||||||||
No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.11M |
$14.32 | -$85,920.00 |
0
|
Nov 28 - Feb 24
| |||
Form 4
| +8.97% | 500K |
$30.00 | $15,000,000.00 | 6.07M |
Aug 11
| |||
Form 4
|
∞
| 5.57M |
$16.00 |
—
| 5.57M |
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vera Therapeutics, Inc. (VERA) Snapshot price: $37.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
| -23.00% | -834.46K |
$40.86 | -$34,099,582.58 | 2.79M |
Mar 21 - Mar 25
| |||
Form 4
| +4.65% | 161.29K |
$31.00 | $4,999,990.00 | 3.63M |
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
| +8.98% | 285.71K |
$7.00 | $1,999,998.00 | 3.47M |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
| +9.15% | 266.67K |
$15.00 | $3,999,990.00 | 3.18M |
Feb 10
| |||
Form 4
|
∞
| 2.91M |
$11.00 |
—
| 2.91M |
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||